“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”.Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimbaldeston, Divya Mohan and Kian Fan Chung.Eur Respir Rev 2023; 32: 220144

Source: Eur Respir Rev, 32 (168) 225144; 10.1183/16000617.5144-2022

Journal Issue: June

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”.Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimbaldeston, Divya Mohan and Kian Fan Chung.Eur Respir Rev 2023; 32: 220144. Eur Respir Rev, 32 (168) 225144; 10.1183/16000617.5144-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.